GLP-1 Receptor Agonists: A Game-Changer for Type 2 Diabetes, Obesity, and Cardiometabolic Health
GLP-1 receptor agonists are changing how we manage more than just blood glucose. APRNs are using these therapies to support weight loss, reduce cardiovascular risk, and improve patient outcomes across the board.